| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Jul 24, 2015
Perrigo Company plc (NYSE: PRGO; TASE) today announced that it will release financial results for its second quarter calendar year 2015 on Wednesday, August 5, 2015 at approximately 8:00 a.m....
-
Jul 22, 2015-- Exemplifies Perrigo's unique brand-building capabilities and impressive distribution network across Europe
Perrigo Company plc ("Perrigo") (NYSE: PRGO; TASE) today announced that it has entered into an agreement to acquire Naturwohl Pharma GmbH with its leading German dietary supplement brand, Yokebe....
-
Jun 16, 2015
Perrigo Company plc (NYSE: PRGO; TASE) today announced that Perrigo Executive Vice President and CFO Judy Brown will present at the Oppenheimer 15th Annual Global Consumer Conference at 11:45 AM ET on
-
Jun 2, 2015-- Portfolio includes well-established European brands in the areas of nicotine replacement therapy, cold and flu, and cold sore management
Perrigo Company plc ("Perrigo") (NYSE: PRGO; TASE) today announced that it has entered into an agreement to acquire a portfolio of well-established over-the-counter ("OTC") brands from...
-
May 27, 2015
Perrigo Company plc (NYSE: PRGO; TASE) today announced that Perrigo Chairman, President and CEO Joseph C. Papa will present at the Jefferies 2015 Healthcare Conference at 4:30 PM EDT on Tuesday,...
-
May 12, 2015
Perrigo Company plc (NYSE: PRGO; TASE) today announced that Perrigo Chairman, President and CEO Joseph C. Papa will present at the 2015 UBS Global Healthcare Conference at 11:30AM EST on Monday,...
-
May 12, 2015-- Further strengthens Perrigo's supply chain capabilities with the addition of softgel manufacturing technology
Perrigo Company plc (NYSE: PRGO; TASE) announced today that it has acquired the Mexican operations of Durham, North Carolina-based Patheon for $34 million in cash. The acquisition is expected to...
-
May 5, 2015
Perrigo Animal Health, a division of Perrigo Company plc (NYSE: PRGO; TASE), today announced that it has launched PetArmor® Joint Health Maximum. PetArmor Joint Health Maximum is a supplement for...
-
Apr 30, 2015
Perrigo Company plc (NYSE: PRGO; TASE) today announced that Perrigo Chairman, President and CEO Joseph C. Papa will present at the 2015 Deutsche Bank 40th Annual Healthcare Conference at 11:20AM...
-
Apr 29, 2015Offer Remains Below Initial April 8th Proposal Based on Unaffected Mylan Stock Price
Perrigo Company plc ("Perrigo") (NYSE: PRGO; TASE) today announced its rejection of the revised unsolicited offer from Mylan NV ("Mylan") (NASDAQ: MYL) to acquire all of the outstanding shares of...
-
Apr 28, 2015
Perrigo Company plc (NYSE: PRGO; TASE) today announced that its Board of Directors declared a quarterly dividend of $0.125 per share, payable on June 16, 2015 to shareholders of record on May 29,...
-
Apr 24, 2015Offer Significantly Below Prior Proposal Based on Unaffected Mylan Stock Price
Perrigo Company plc ("Perrigo" or the "Company") (NYSE: PRGO, TASE) today announced its rejection of the unsolicited offer from Mylan NV ("Mylan") (NASDAQ: MYL) to acquire all of the outstanding...
-
Apr 22, 2015
Dublin, Ireland – April 22, 2015 – On April 16, Perrigo Company plc (NYSE: PRGO; TASE) announced it had received final U.S. Food and Drug Administration approval and had launched the...
-
Apr 21, 2015Company Provides Guidance for Calendar Year 2015 and Three-Year Organic Net Sales Growth Rate Goals
Third Quarter FY 2015 Highlights: Delivered record fiscal third quarter net sales of $1.05 billion. Excluding the effect of the pre-closing debt and equity issuances related to the Omega Pharma...
-
Apr 21, 2015This is an announcement falling under Rule 2.4 of Irish Takeover Panel Act, 1997, Takeover Rules, 2013 (the "Irish Takeover Rules").
Perrigo Company plc ("Perrigo") (NYSE: PRGO; TASE) today announced that its Board of Directors has unanimously rejected the unsolicited Proposal (the "Proposal") from Mylan NV ("Mylan") (NASDAQ:...
-
Apr 20, 2015
Thousands of law enforcement K-9s put their lives on the line to protect America on a daily basis. They are usually the first officer to enter a dangerous situation, and help track and neutralize...
-
Apr 16, 2015
Perrigo Company plc (NYSE: PRGO; TASE) today announced that it has received final Federal Drug Administration approval for Triamcinolone Acetonide Topical Aerosol, the generic version of Sun...
-
Apr 8, 2015This is an announcement falling under Rule 2.4 of Irish Takeover Panel Act, 1997, Takeover Rules, 2013 (the "Takeover Rules").
Perrigo Company plc ("Perrigo" or the "Company") (NYSE: PRGO; TASE) notes the announcement made by Mylan NV ("Mylan") (NASDAQ: MYL). Perrigo confirms that it has received an unsolicited,...
-
Apr 8, 2015
Perrigo Company plc (NYSE: PRGO; TASE) today announced that it has received final approval from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug Application for...
-
Mar 30, 2015- Advances Perrigo's stated strategy to expand internationally and leverage the combined product portfolio of Perrigo and Omega
Perrigo Company plc (NYSE: PRGO; TASE), a leading global provider of "Quality Affordable Healthcare Products®," today announced that it has completed the acquisition of Belgian-based Omega Pharma...
-
Mar 4, 2015
Booth No. 2615 -- Perrigo Animal Health, a division of Perrigo Company plc (NYSE: PRGO; TASE), showcased two new product lines at the 2015 Global Pet Expo: SENTRY® Fiproguard® Plus and SENTRY®...
-
Mar 4, 2015Booth No. 2601
Perrigo Animal Health, a division of Perrigo Company plc (NYSE: PRGO); (TASE: PRGO), showcased two new product lines at the 2015 Global Pet Expo: PetArmor® Plus and PetArmor® Soft & Chewy...
-
Mar 4, 2015
Perrigo Company plc (NYSE: PRGO; TASE) today announced that Perrigo Chairman, President and CEO Joseph C. Papa will present at the 2015 Barclays Global Healthcare Conference at 8:00AM ET on...
-
Feb 17, 2015
Perrigo Company plc (NYSE: PRGO; TASE) today announced that Perrigo Chairman, President and CEO Joseph C. Papa will present at the 2015 RBC Global Healthcare Conference at 4:35PM EST on Tuesday,...
-
Feb 5, 2015
Fiscal second quarter net sales increased to a second quarter record of $1.07 billion. Excluding the effect of the pre-closing debt and equity issuances related to the previously announced...
-
Jan 29, 2015
Perrigo Company plc (NYSE: PRGO; TASE) today announced that it will release financial results for its second quarter fiscal year 2015 on Thursday, February 5, 2015 at approximately 7:30 a.m. (ET)....
-
Jan 27, 2015
Perrigo Company plc (NYSE: PRGO; TASE) today announced that its Board of Directors declared a quarterly dividend of $0.125 per share, payable on March 17, 2015 to shareholders of record on...
-
Jan 22, 2015
Perrigo Company plc (NYSE: PRGO; TASE) today announced that it will release financial results for its second quarter fiscal year 2015 on Thursday, February 5, 2015 at approximately 8:00 a.m. (ET)....
-
Jan 12, 2015
Perrigo Company plc (NYSE: PRGO; TASE) today announced that it has launched its AB therapeutic equivalent testosterone gel 1.0%. The Food and Drug Administration (FDA) concluded previously that...
-
Jan 12, 2015
Perrigo Company plc (NYSE: PRGO; TASE), and Ferrara Candy Company, Inc. ("Ferrara"), announced today that Perrigo's Nutritionals division has signed a supply agreement with Ferrara to manufacture...
-
Jan 12, 2015
Perrigo Company plc (NYSE: PRGO; TASE) today announced that it has launched clobetasol propionate spray, 0.05%, the generic equivalent to Clobex® Spray, 0.05%. Perrigo was the first generic filer...
-
Jan 6, 2015
Perrigo Company plc (NYSE: PRGO; TASE) today announced that Perrigo Chairman, President and CEO Joseph C. Papa will present at the 33rd Annual J.P. Morgan Healthcare Conference on Monday, January...
-
Dec 2, 2014
Perrigo Company plc ("Perrigo") (NYSE: PRGO; TASE), a leading global provider of "Quality Affordable Healthcare Products®," today announced the closing of the previously announced registered...
-
Dec 2, 2014
Perrigo Company plc (NYSE: PRGO; TASE) today announced that it has received final approval from the U.S. Food and Drug Administration (FDA) on its Abbreviated New Drug Application (ANDA) for...
-
Nov 26, 2014
Perrigo Company plc ("Perrigo") (NYSE: PRGO; TASE), a leading global provider of "Quality Affordable Healthcare Products®," today announced the closing of Perrigo's previously announced...
-
Nov 24, 2014
Perrigo Company plc ("Perrigo") (NYSE: PRGO; TASE), a leading global provider of "Quality Affordable Healthcare Products®," today announced the pricing of the registered public offering by...
-
Nov 24, 2014
Perrigo Company plc ("Perrigo") (NYSE: PRGO; TASE), a leading global provider of "Quality Affordable Healthcare Products®," today announced that the underwriters for Perrigo's previously...
-
Nov 24, 2014
Perrigo Company plc ("Perrigo") (NYSE: PRGO; TASE), a leading global provider of "Quality Affordable Healthcare Products®," today announced that Perrigo Finance plc, a finance subsidiary of...
-
Nov 24, 2014
Perrigo Company plc (NYSE: PRGO; TASE) today announced that it has filed with the U.S. Food and Drug Administration (FDA) an Abbreviated New Drug Application for testosterone undecanoate injection...
-
Nov 24, 2014
Perrigo Company plc (NYSE: PRGO; TASE) today announced that it has agreed to market the authorized generic version of Astellas U.S. LLC's' Protopic® Ointment 0.1% and 0.03%. Shipments to our...
-
Nov 20, 2014
Perrigo Company plc ("Perrigo") (NYSE: PRGO; TASE), a leading global provider of "Quality Affordable Healthcare Products®," today announced the pricing of the registered public offering of...
-
Nov 20, 2014
Perrigo Company plc ("Perrigo") (NYSE: PRGO; TASE), a leading global provider of "Quality Affordable Healthcare Products®," today announced that it is commencing a registered public offering of...
-
Nov 6, 2014
Perrigo Company plc (NYSE: PRGO; TASE) announced today that it has reinitiated shipments of Guaifenesin 600mg Extended-Release tablets to its retail and wholesale customers in the United States....
-
Nov 6, 2014
Fiscal first quarter net sales increased to a first quarter record of $952 million. Fiscal first quarter adjusted net income increased 30% to a first quarter record of $188 million, with reported...
-
Nov 6, 2014- Accelerates Perrigo's stated strategy to expand internationally and leverage its existing product portfolio
Perrigo Company plc (NYSE: PRGO; TASE), a leading global provider of "Quality Affordable Healthcare Products®," and Omega Pharma NV, one of the largest OTC healthcare companies in Europe,...
-
Nov 3, 2014
Perrigo Company plc (NYSE: PRGO;TASE) today announced that its Board of Directors declared a quarterly dividend of $0.105 per share, payable on December 16, 2014 to shareholders of record on...
-
Oct 23, 2014
Perrigo Company plc (NYSE: PRGO; TASE) today announced that it will release financial results for its first quarter fiscal year 2015 on Thursday, November 6, 2014 at approximately 8:00 a.m. (ET)....
-
Oct 14, 2014
Perrigo Animal Health, a division of Perrigo Company plc (NYSE: PRGO; TASE), is proud to announce that its Kansas City, Kansas, manufacturing facility has obtained Safety Quality Food (SQF) Code...
-
Oct 2, 2014
Perrigo Company plc (NYSE: PRGO; TASE), a public limited company incorporated under the laws of Ireland (the "Company"), today announced the expiration of its offer to exchange (the "Exchange...
-
Oct 1, 2014
Perrigo Company plc (NYSE: PRGO; TASE), a public limited company incorporated under the laws of Ireland (the "Company"), today announced the extension of its offer to exchange (the "Exchange...